Torrent Pharma shares fall over 3 pc post Q4 results

Image
Press Trust of India New Delhi
Last Updated : May 21 2019 | 4:51 PM IST

Shares of Torrent Pharmaceuticals Tuesday declined over 3 per cent a day after it reported a loss of Rs 152 crore for the quarter ended March 31, 2019.

The stock on the BSE opened on a negative note of Rs 1,634.90 and further slipped to touch the intra-day low of Rs 1,525.20. The scrip finally settled at Rs 1,601.05 with a loss of 3.30 per cent over its previous close.

On the NSE the scrip closed at Rs 1,600, declining 3.29 per cent. Intra-day it touched a low of Rs 1,525.35.

In terms of the equity volume, a combined of over 17 lakh shares were traded on the stock exchanges during the day.

The company had posted a profit of Rs 228 crore in the same quarter of 2017-18 financial year, as per a BSE filing on Monday.

The net loss of Rs 152 crore in the latest quarter is on account of exceptional items of Rs 357 crore and lower hedging gains, the company said.

Out of Rs 357 crore worth exceptional items, Rs 217 crore pertains to impairment provision of certain intangible assets under development and goodwill recognised with respect to the acquisition of Bio-Pharm Inc.

An amount of Rs 140 crore is in relation to product recalls made during the current year, the drug firm said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 21 2019 | 4:51 PM IST

Next Story